ArticlePediatric cardiology2026
Pulmonary Artery Size as a Predictor of Early Post-operative Pediatric and Congenital Heart Transplant Outcomes.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary artery size has been studied as an outcome predictor for selected congenital heart surgeries but has not been investigated in pediatric and congenital heart transplantation. We sought to evaluate pre-operative pulmonary artery size as a predictor of post-transplant outcomes. This single center retrospective study included all patients transplanted from 2014 to 2023. Echocardiography, computed tomography angiography (CTA), and catheter angiography were used to measure pre-operative pulmonary artery size. Cross-sectional areas were calculated and indexed to calculate Nakata index and lower lobe index. Outcomes included post-transplant cardiovascular and end-organ function, length of stay, and mortality. Statistical analyses included Spearman rank correlations, chi-squared tests, and Mann-Whitney U tests. Included were 68 patients with 37 (54%) having a diagnosis of congenital heart disease. Echocardiogram (n = 68), CTA (n = 52), and catheter angiogram (n = 31) measurements were analyzed. Smaller lower lobe index was associated with longer duration of post-transplant treatment with nitric oxide (p = 0.02). In the congenital heart disease cohort, smaller Nakata index was associated with pulmonary artery reconstruction during transplant (p = 0.003). Indexed pulmonary artery size was otherwise not associated with important outcomes in the entire population or congenital heart disease cohort. While pre-operative pulmonary artery size was associated with prolonged nitric oxide use, it was generally not predictive of other early post-transplant outcomes. No imaging modality was found to have superior predictive value. Use of advanced imaging to guide surgical technique during transplant may negate the impact of smaller pulmonary artery size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.